Traws Pharma
TRAW
TRAW
17 hedge funds and large institutions have $5.92M invested in Traws Pharma in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 4 closing their positions.
Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
6
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
6CM
1
683 Capital Management
New York
|
$2.23M |
2 |
AC
2
Armistice Capital
New York
|
$1.13M |
3 |
TCP
3
Tyndall Capital Partners
New York
|
$1.75M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$287K |
5 |
5
Renaissance Technologies
New York
|
$123K |
Top Sellers
1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$334K |
2 |
VF
2
Virtu Financial
New York
|
$0 |
3 |
3
Citadel Advisors
Miami,
Florida
|
$0 |
4 |
4
Macquarie Group
Sydney, NSW 2000,
Australia
|
$0 |